4D MOLECULAR THERAPEUTICS IN's ticker is and the CUSIP is 35104E950. A total of 2 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | -89.6% | 400 | -85.2% | 0.00% | – |
| Q2 2023 | $48 | -94.4% | 2,700 | -94.6% | 0.00% | -100.0% |
| Q1 2023 | $864 | +10700.0% | 50,300 | +12475.0% | 0.00% | – |
| Q4 2022 | $8 | -99.8% | 400 | -50.0% | 0.00% | – |
| Q2 2022 | $5,000 | +150.0% | 800 | +700.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 50,300 | $864 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |